📆 السبت   2023-09-23

🕘 11:48 AM بتوقيت مكة

 
coagulation modifiers
antiplatelet agents
Antiplatelet agents are medicines that reduce the ability of platelets to stick together (called platelet aggregation) and inhibit the formation of blood clots.
Antiplatelet agents play a major role in the treatment and prevention of myocardial infarction (heart attacks), stent thrombosis, and ischemic stroke (strokes caused by a blood clot).

Drug classes:

 

Ⓖ Abciximab


® ReoPro

 

Ⓖ Aspirin and dipyridamole


® Aggrenox

 

Ⓖ Aspirin and omeprazole


® Yosprala

 

Ⓖ Cangrelor


® Kengreal

 

Ⓖ Caplacizumab-yhdp


® Cablivi

 

Ⓖ Cilostazol


® Pletal





 
اخلاء المسؤولية
لا تتحمل الشبكة، أي مسؤولية عن أي خسائر أو أضرار قد تنجم عن استخدام الموقع.

🆆🅷🅸🆃🅴🅲🆁🅴🆂🅲🅴🅽🆃.🅝🅔🅣

دخول
تسجيل